The following stories appear in full on today's Vidyya Medical News Service Web site.
Cedara Software Corp. today announced clearance from the United States Food and Drug Administration (FDA) to market the Cedara(TM) Software for the Heart cardiac imaging application to equipment manufacturers in the United States. The Cedara web-enabled viewer allows qualified medical professionals to capture, retrieve, display, manipulate, measure, report, and save cardiac or other medical images generated from various modalities and sources.
The Food and Drug Administration (FDA) is warning consumers not to purchase or consume various canned soups imported from Canada because they have the potential to be contaminated with Clostridium botulinum, a bacterium which can cause life-threatening illness or death. Consumers are not to use the products even if they do not look or smell spoiled. Les Produits Freddy Inc. (St-Hyacinthe, Quebec), a Canadian firm, has begun a voluntary recall of the products. FDA is taking this action as a result of the Canadian government's evaluation.
As of 24 November, the Ugandan Ministry of Health reported the following laboratory confirmed cases during the past week, 17-23 November: In Gulu district, there have been 15 laboratory confirmed cases. During the week, there were 14 deaths. The Ugandan Ministry of Health has reported cumulative figures of 337 cases, including 121 deaths. Deaths have been reported in two outside districts, although spread of the disease to these areas appears to be under strict control.
Aventis CropScience said today that it has confirmed the presence of Cry9C protein in test samples of a variety of corn seed that was not sold under the StarLink trademark. Aventis has notified the EPA, FDA, and USDA of its findings, and is consulting with these agencies to determine next steps.
According to physicians in the UK, pregnant women should not stop taking iron tablets, despite research published in last week's JAMA that links high haemoglobin to stillbirth.
As always, we hope you enjoy the issue.